Adaptive Biotechnologies Corp financial data

Symbol
ADPT on Nasdaq
Location
1165 Eastlake Ave E, Seattle, WA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 1, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 332 % -29.6%
Quick Ratio 11.7 % -36.5%
Debt-to-equity 156 % +46.6%
Return On Equity -66.2 % -3.09%
Return On Assets -25.9 % +16.9%
Operating Margin -75.7 % +39.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 152M shares +3.09%
Common Stock, Shares, Outstanding 152M shares +3.09%
Entity Public Float 416M USD -45%
Common Stock, Value, Issued 15K USD +7.14%
Weighted Average Number of Shares Outstanding, Basic 149M shares +2.34%
Weighted Average Number of Shares Outstanding, Diluted 149M shares +2.34%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 190M USD +8.61%
Research and Development Expense 96.9M USD -19.1%
Selling and Marketing Expense 85.5M USD -3.5%
General and Administrative Expense 70.6M USD -14.6%
Costs and Expenses 333M USD -15.3%
Operating Income (Loss) -143M USD +34.4%
Net Income (Loss) Attributable to Parent -142M USD +34%
Earnings Per Share, Basic -1 USD/shares +36.2%
Earnings Per Share, Diluted -1 USD/shares +36.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 50.6M USD -28.9%
Accounts Receivable, after Allowance for Credit Loss, Current 43.6M USD +3.72%
Inventory, Net 8.68M USD -34.7%
Assets, Current 256M USD -31.4%
Property, Plant and Equipment, Net 44.4M USD -31.9%
Operating Lease, Right-of-Use Asset 44M USD -13.7%
Goodwill 119M USD 0%
Other Assets, Noncurrent 1.89M USD -44.4%
Assets 511M USD -17.6%
Accounts Payable, Current 6.36M USD -47.7%
Employee-related Liabilities, Current 6.41M USD +0.13%
Accrued Liabilities, Current 7.76M USD -1.98%
Contract with Customer, Liability, Current 54.8M USD +16.9%
Liabilities, Current 87.8M USD +5.86%
Contract with Customer, Liability, Noncurrent 24.8M USD -43.8%
Operating Lease, Liability, Noncurrent 76.4M USD -12%
Other Liabilities, Noncurrent 20K USD
Liabilities 321M USD -7.21%
Accumulated Other Comprehensive Income (Loss), Net of Tax 134K USD
Retained Earnings (Accumulated Deficit) -1.33B USD -11.9%
Stockholders' Equity Attributable to Parent 190M USD -30.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 190M USD -30.8%
Liabilities and Equity 511M USD -17.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.5M USD +25.7%
Net Cash Provided by (Used in) Financing Activities 5.45M USD +12289%
Net Cash Provided by (Used in) Investing Activities 25.6M USD -42.5%
Common Stock, Shares Authorized 340M shares 0%
Common Stock, Shares, Issued 152M shares +3.09%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.54M USD -59%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.37M USD +3.67%
Deferred Tax Assets, Valuation Allowance 436M USD +8.22%
Deferred Tax Assets, Gross 447M USD +7.23%
Operating Lease, Liability 86.9M USD -9.94%
Depreciation 4.31M USD -10%
Payments to Acquire Property, Plant, and Equipment 1.26M USD -16.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -142M USD +33.6%
Lessee, Operating Lease, Liability, to be Paid 104M USD -11.7%
Property, Plant and Equipment, Gross 136M USD -3.55%
Operating Lease, Liability, Current 10.5M USD +9.05%
Lessee, Operating Lease, Liability, to be Paid, Year Two 11.9M USD -3.13%
Lessee, Operating Lease, Liability, to be Paid, Year One 12.3M USD -12.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 17.2M USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 12.3M USD +2.83%
Deferred Tax Assets, Operating Loss Carryforwards 275M USD +9.06%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 10.7M USD +15.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.6M USD +2.83%
Operating Lease, Payments 3M USD -18.9%
Additional Paid in Capital 1.52B USD +3.89%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.7M USD -0.24%
Deferred Tax Assets, Net of Valuation Allowance 11.6M USD -20.2%
Share-based Payment Arrangement, Expense 51.5M USD -17.7%
Interest Expense 11.5M USD -13.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%